Last Modified: June 1, 2008
Conference Dates: November 5, 2008
Conference Location: Baltimore, Maryland
Sponsoring Group: Abcam, Inc.
Conference Web Page URL: http://www.abcam.com/Baltimore
Topics Covered: The meeting will cover multidrug resistance in cancer and ABC transporters - basic, clinical, regulation and drug-drug interaction aspects.
Conference Objectives: Multidrug resistance in cancer and ABC transporters
Conference Agenda: Confirmed speakers: [Keynote] Dr Michael M. Gottesman (National Cancer Institute, NIH), Current status of multidrug resistance and ABC transporters - Dr Robert B. Innis (Molecular Imaging Branch, NIMH), Positron emission tomographic imaging of drug efflux transporters - Dr David S. Miller (NIEHS, NIH), Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier - Dr Gilbert J. Burckart (U.S. Food and Drug Administration), Drug-drug interactions and regulatory implications for membrane transporter substrates in drug development - Dr Maria R. Baer (University of Maryland Greenebaum Cancer Center), Clinical and therapeutic implications of multidrug resistance-associated ABC drug transporters - Dr Suresh V. Ambudkar (National Cancer Institute), Mechanism of action of multidrug resistance-linked ABC drug transporters
Registration Information: Oral abstract deadline: August 5, 2008 Poster abstract deadline: October 5, 2008 Early bird discount deadline: September 5, 2008
Conference Fees: $125.00
Continuing Education: No
Oct 4, 2011 - Following paclitaxel exposure in breast cancer, multidrug sensitization due to depletion of a ceramide transporter augments autophagy, resulting in lysosomal-associated membrane protein 2-dependent death of multinucleated cells, according to a study published online Sept. 26 in The Journal of Pathology.